[ARWR] YoY Annual Result on 30-Sep-2012 [#FY]

Stock
[ARWR] Arrowhead Pharmaceuticals, Inc.
Announcement Date
28-Dec-2012
Financial Year
2012
Quarter
30-Sep-2012 [#FY]
Profit Trend
YoY- -575.17%
Quarter Report
ARWR's Result
ARWR's Financial Summary
View:
Show?
Annual Result
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
Revenue 382 175 290 147 296 620 3,773 -31.71%
PBT -91,938 -58,720 -31,703 -22,111 -8,785 -7,336 -19,158 29.85%
Tax 2 5 6,223 -203 -6,865 -3,248 54 -42.25%
NP -91,941 -58,630 -31,143 -21,126 -3,129 -5,774 -19,308 29.69%
Tax Rate - - - - - - - -
Total Cost 92,323 58,805 31,434 21,273 3,425 6,394 23,082 25.97%
Ratio Analysis
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
NP Margin -24,068.29 -33,502.97 -10,729.22 -14,383.61 -1,056.56 -931.15 -511.73 89.93%
Per Share
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
EPS -1.60 -1.25 -1.30 -1.90 -0.44 -0.90 -4.27 -15.08%
EPS Diluted -1.60 -1.25 -1.30 -1.90 -0.44 -0.90 -4.27 -15.08%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.